Apart from the treatment, the most important thing will be for the ROW to see the effectiveness of Inavir (LANI) in Japan and for this to fast-track the ROW clinical trials/approval process.
BTA Price at posting:
99.0¢ Sentiment: LT Buy Disclosure: Held
